Patents by Inventor Mitchell G. Thompson

Mitchell G. Thompson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VIRULENCE PLASMIDS FOR AGROBACTERIUM MEDIATED EUKARYOTIC TRANSFORMATION
    Publication number: 20250115922
    Abstract: The present invention provides for a nucleic acid encoding refactored minimized set of Agrobacterium virulence genes. The present invention provides for a method for introducing a nucleic acid of interest into a eukaryotic cell, the method comprises: (a) providing (i) a first nucleic acid encoding a refactored minimized set of Agrobacterium virulence genes operatively linked to one or more promoters; and (ii) a second nucleic acid comprising a nucleic acid of interest flanked by a left border and a right border; (b) introducing the first nucleic acid and the second nucleic acid into a target host cell; and, (c) the nucleic acid of interest is stably integrated into a genome of the target host cell.
    Type: Application
    Filed: October 4, 2024
    Publication date: April 10, 2025
    Inventors: Mitchell G. THOMPSON, Allison N. PEARSON, Patrick M. SHIH
  • MURINE WOUND MODEL FOR TESTING PATHOGEN VIRUENCE AND THERAPEUTIC EFFICACY
    Publication number: 20170173186
    Abstract: The invention provides a murine model of wound infection and biofilm formation and methods for producing such model. The inventive murine model of wound infection may be used to evaluate pathogen virulence and test efficacy of a pharmaceutical composition and/or a treatment procedures in preventing or treating wound infection, reducing biofilm formation, or reducing symptoms in a subject.
    Type: Application
    Filed: December 15, 2014
    Publication date: June 22, 2017
    Inventors: Rebecca L. Pavlicek, Daniel V. Zurawski, Mitchell G. Thompson, Chad C. Black
  • MURINE WOUND MODEL FOR TESTING PATHOGEN VIRUENCE AND THERAPEUTIC EFFICACY
    Publication number: 20160166712
    Abstract: The invention provides a murine model of wound infection and biofilm formation and methods for producing such model. The inventive murine model of wound infection may be used to evaluate pathogen virulence and test efficacy of a pharmaceutical composition and/or a treatment procedures in preventing or treating wound infection, reducing biofilm formation, or reducing symptoms in a subject.
    Type: Application
    Filed: December 15, 2014
    Publication date: June 16, 2016
    Inventors: Rebecca L. Pavlicek, Daniel V. Zurawski, Mitchell G. Thompson, Chad C. Black